Because of their shared routes of transmission, HCV coinfection with HIV is remarkably frequent in the U.S., particularly among injection drug users (IDU). With the success of HAART, traditional opportunistic infections among HIV-infected persons have been replaced by end stage liver disease due to viral hepatitis, particularly HCV. The most important clinical features of HCV in HIV-infected persons compared to HIV- negative persons are (1) its higher rates of persistence;(2) low rates of response to interferon (IFN) based antiviral therapy;and (3) accelerated hepatic fibrosis progression. Using cell-based models of HCV replication, we have recently shown that STAT1 is the principal innate antiviral component against HCV. We further demonstrated that HCV selectively degrades STAT1 and impairs type I IFN signaling in a proteasome-dependent manner. This action is mediated through the interaction of HCV core protein with STAT1. We have observed that recombinant HIV gp120 enhances HCV production in an HCV replicon model and impairs type I IFN signaling. Finally, we have demonstrated that HCV core and NS5A directly upregulate TGF-beta1, the principal fibrogenic cytokine. We hypothesize that HIV augments HCV's suppressive effects on IFN signal transduction and that it promotes HCV's effects on TGF-beta1 in the liver. We propose to: (1) define the mechanism of HIV's proviral effect on HCV replication and (2) characterize the effect of HIV on HCV regulation of TGF-beta1 in the liver.
For Aim 1, we will (a) characterize the effect of gp120 on HCV-induced STAT1 degradation and suppression of IFN signaling;(b) determine whether gp120's proviral effects on HCV are reversed by restoration of type I IFN signaling;(c) evaluate the signaling mechanism by which gp120 regulates HCV replication;and (d) assess the effect of gp120 on IFN-stimulated genes and upstream genes.
For Aim 2, we will (a) define how HCV regulates TGF-beta1 expression in hepatocyte-derived cell lines;(b) determine whether gp120 independently regulates TGF-beta1 expression in hepatocytes;(c) determine how gp120 modifies HCV regulation of TGF-beta1 expression in HCV replication models;and (d) determine whether gp120 enhances fibrogenic signals released by hepatocytes harboring HCV. These studies will shed considerable light on HIV-HCV pathogenic interactions and offer a means of productively disrupting these interactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI069939-05
Application #
7888318
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Brobst, Susan W
Project Start
2006-07-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
5
Fiscal Year
2010
Total Cost
$371,317
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Qu, Chen; Zheng, Dandan; Li, Sai et al. (2018) Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology :
Duan, Xiaoqiong; Li, Shilin; Holmes, Jacinta A et al. (2018) MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway. J Virol 92:
Liu, Xiao; Duan, Xiaoqiong; Holmes, Jacinta A et al. (2018) A novel lncRNA regulates HCV infection through IFI6. Hepatology :
Chusri, Pattranuch; Kumthip, Kattareeya; Hong, Jian et al. (2016) HCV induces transforming growth factor ?1 through activation of endoplasmic reticulum stress and the unfolded protein response. Sci Rep 6:22487
Gogela, Neliswa A; Lin, Ming V; Wisocky, Jessica L et al. (2015) Enhancing our understanding of current therapies for hepatitis C virus (HCV). Curr HIV/AIDS Rep 12:68-78
Jang, Jae Young; Kim, Seong-Jun; Cho, Eun Kyung et al. (2014) TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications. PLoS One 9:e98171
Lin, Wenyu; Weinberg, Ethan M; Chung, Raymond T (2013) Pathogenesis of accelerated fibrosis in HIV/HCV co-infection. J Infect Dis 207 Suppl 1:S13-8
Shao, Run-Xuan; Zhang, Leiliang; Hong, Zhi et al. (2013) SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication. Antiviral Res 97:101-7
Hoshida, Yujin; Villanueva, Augusto; Sangiovanni, Angelo et al. (2013) Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 144:1024-30
Goto, Kaku; Lin, Wenyu; Zhang, Leiliang et al. (2013) The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-* signaling. J Hepatol 59:942-8

Showing the most recent 10 out of 35 publications